NPC
NYMX

National Planning Corporation’s Nymox Pharmaceutical Corp NYMX Stock Holding History

National Planning Corporation’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,000
Closed -$42K – 659
2017
Q3 		$42K Hold
11,000
– – ﹤0.01% 675
2017
Q2 		$46K Hold
11,000
– – ﹤0.01% 730
2017
Q1 		$41K Hold
11,000
– – ﹤0.01% 698
2016
Q4 		$36K Hold
11,000
– – ﹤0.01% 684
2016
Q3 		$32K Hold
11,000
– – ﹤0.01% 647
2016
Q2 		$37K Hold
11,000
– – ﹤0.01% 655
2016
Q1 		$26K Sell
11,000
-5,200
-32% -$12.3K ﹤0.01% 635
2015
Q4 		$33K Buy
16,200
+5,200
+47% +$17.4K ﹤0.01% 718
2015
Q3 		$40K Buy
+11,000
New +$25.6K ﹤0.01% 612
2015
Q1 		– Sell
-9,200
Closed -$3.4K – 2174
2014
Q4 		$3.4K Buy
+9,200
New +$19.6K ﹤0.01% 2452

Other funds holding NYMX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

National Planning Corporation's NYMX Position: Q4 2017 in Review

National Planning Corporation sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2017, closing a stake of 11,000 shares — an estimated $42K sold.

National Planning Corporation first reported a position in NYMX in Q4 2014 and held it in 10 quarters. The position peaked at $46K in Q2 2017. 41 funds tracked by Wall St. Rank hold NYMX as of Q4 2017.

  • National Planning Corporation reported no remaining Nymox Pharmaceutical Corp position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 11,000 Nymox Pharmaceutical Corp shares in Q4 2017, an estimated $42K.
  • National Planning Corporation first reported a position in Nymox Pharmaceutical Corp in Q4 2014 and held it in 10 quarters.
  • National Planning Corporation's Nymox Pharmaceutical Corp position peaked at $46K in Q2 2017.
  • 41 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.